Page 10 - Infi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Infi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Infi Today - Breaking & Trending Today

Infinity Pharmaceuticals (NASDAQ:INFI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Free Report) in a report released on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. Infinity Pharmaceuticals Price Performance Shares of NASDAQ:INFI opened at $0.10 on Friday. The business’s 50 day moving average price is $0.17 and its 200-day moving […] ....

Infinity Pharmaceuticals Price Performance , Callan Capital , News Ratings For Infinity Pharmaceuticals Daily , Infinity Pharmaceuticals Inc , Infinity Pharmaceuticals , Virtu Financial , Mirabella Financial Services , Free Report , Financial Services , Sigma Investments , Street Group , Get Free Report , Infinity Pharmaceuticals Daily , Nasdaq Infi , Initiated Coverage , Stocknews Com ,

Infinity Pharmaceuticals, Inc. : Please contact the Portnoy

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 21, 2023 (GLOBE NEWSWIRE) The Portnoy Law. ....

Lesleyf Portnoy , Portnoy Law Firm , Infinity Pharmaceuticals Inc , Infinity Pharmaceuticals , Class Period , Portnoy Law , Lass Action ,

NFI Group reports US$48.1-million quarterly loss as it seeks to ramp up production in second half of 2023

NFI chief executive Paul Soubry says the company expects some temporary inefficiencies as it looks to increase production, but it sees a path for significant margin growth in 2024 and 2025 ....

Paul Soubry , Group Inc , Log Increate Free , Nfi Group Inc ,